Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1977 1
1980 1
1983 1
1984 2
1987 1
1989 2
1992 1
1993 2
1994 1
1995 2
1996 3
1998 6
1999 2
2000 5
2001 7
2002 2
2003 7
2004 13
2005 10
2006 9
2007 17
2008 14
2009 17
2010 21
2011 14
2012 20
2013 23
2014 16
2015 14
2016 12
2017 17
2018 16
2019 14
2020 32
2021 28
2022 17
2023 13
2024 6

Text availability

Article attribute

Article type

Publication date

Search Results

336 results

Results by year

Filters applied: . Clear all
Page 1
Nivolumab plus chemotherapy or ipilimumab versus chemotherapy in patients with advanced esophageal squamous cell carcinoma (CheckMate 648): 29-month follow-up from a randomized, open-label, phase III trial.
Kato K, Doki Y, Chau I, Xu J, Wyrwicz L, Motoyama S, Ogata T, Kawakami H, Hsu CH, Adenis A, El Hajbi F, Di Bartolomeo M, Braghiroli MI, Holtved E, Makino T, Blum Murphy M, Amaya-Chanaga C, Patel A, Hu N, Matsumura Y, Kitagawa Y, Ajani J. Kato K, et al. Among authors: motoyama s. Cancer Med. 2024 May;13(9):e7235. doi: 10.1002/cam4.7235. Cancer Med. 2024. PMID: 38716626 Free PMC article. Clinical Trial.
Circulating IL-6 and not its circulating signaling components sIL-6R and sgp130 demonstrate clinical significance in NSCLC patients treated with immune checkpoint inhibitors.
Nakahara Y, Kouro T, Motoyama S, Miura M, Fujita K, Igarashi Y, Higashijima N, Matsuo N, Himuro H, Wei F, Horaguchi S, Tsuji K, Mano Y, Komahashi M, Saito H, Azuma K, Sasada T. Nakahara Y, et al. Among authors: motoyama s. Front Cell Dev Biol. 2024 Jan 16;11:1324898. doi: 10.3389/fcell.2023.1324898. eCollection 2023. Front Cell Dev Biol. 2024. PMID: 38469154 Free PMC article.
Preoperative neoadjuvant chemoradiotherapy provides borderline resectable thoracic esophageal cancer with equivalent treatment results as clinically T3 thoracic esophageal cancer.
Wakita A, Motoyama S, Sato Y, Nagaki Y, Fujita H, Kemuriyama K, Hayashi K, Imai K, Nanjo H, Minamiya Y. Wakita A, et al. Among authors: motoyama s. Ann Gastroenterol Surg. 2023 Jun 11;7(6):904-912. doi: 10.1002/ags3.12706. eCollection 2023 Nov. Ann Gastroenterol Surg. 2023. PMID: 37927919 Free PMC article.
Rapid in vitro assessment of the immunogenicity potential of engineered antibody therapeutics through detection of CD4+ T cell interleukin-2 secretion.
Arata Y, Motoyama S, Yano M, Ikuno T, Ito S, Matsushita T, Takeiri A, Nishito Y, Yabuki N, Mizuno H, Sampei Z, Mishima M, Honda M, Kiyokawa J, Suzuki H, Chiba S, Tabo M, Kubo C. Arata Y, et al. Among authors: motoyama s. MAbs. 2023 Jan-Dec;15(1):2253570. doi: 10.1080/19420862.2023.2253570. MAbs. 2023. PMID: 37682072 Free PMC article.
Coronary computed tomography angiographic detection of in-stent restenosis via deep learning reconstruction: a feasibility study.
Kawai H, Motoyama S, Sarai M, Sato Y, Matsuyama T, Matsumoto R, Takahashi H, Katagata A, Kataoka Y, Ida Y, Muramatsu T, Ohno Y, Ozaki Y, Toyama H, Narula J, Izawa H. Kawai H, et al. Among authors: motoyama s. Eur Radiol. 2024 Apr;34(4):2647-2657. doi: 10.1007/s00330-023-10110-7. Epub 2023 Sep 6. Eur Radiol. 2024. PMID: 37672056
336 results